|
| | Sitagliptin Impurity 14 Basic information |
| Product Name: | Sitagliptin Impurity 14 | | Synonyms: | 3-Amino-4-(2,4,5-trifluorophenyl)butanyl Sitagliptin;Sitagliptin impurity 24/3-Amino-4-(2,4,5-trifluorophenyl)butanyl Sitagliptin/(R)-3-amino-N-((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide;(R)-3-amino-N-((R)-4-oxo-4-(3-(trifluoromethyl);Sitagliptin Impurity 18 HCl;Benzenebutanamide, β-amino-N-[(1R)-3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-2,4,5-trifluoro-, (βR)-;(R)-3-amino-N-((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide;(R)-3-amino-N-((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide? (Sitagliptin Impurity）;Benzenebutanamide, β-amino-N-[(1R)-3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-2,4,5-trifluoro-, (βR)- | | CAS: | 2072867-07-1 | | MF: | C26H23F9N6O2 | | MW: | 622.5 | | EINECS: | | | Product Categories: | | | Mol File: | 2072867-07-1.mol |  |
| | Sitagliptin Impurity 14 Chemical Properties |
| Melting point | >73°C (dec.) | | density | 1.57±0.1 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 14.55±0.46(Predicted) | | color | White to Off-White |
| | Sitagliptin Impurity 14 Usage And Synthesis |
| Uses | 3-Amino-4-(2,4,5-trifluorophenyl)butanyl Sitagliptin is an impurity of Sitagliptin (S490990). Sitagliptin is a trizolopyrazine dipeptidyl peptidase IV inhibitor. It has recently been approved for the therapy of type II diabetes. |
| | Sitagliptin Impurity 14 Preparation Products And Raw materials |
|
